Top Markets
Coin of the day
AegirBio AB (publ) AegirBio AB (publ)

AegirBio AB (publ)

AEGIR
Clasificación en acciones #38668
AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden.... AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden. The company specializes in developing and commercializing tests primarily aimed at monitoring the dosage of biological drugs. Their efforts are concentrated on therapeutic drug monitoring for biologic therapies across various conditions, including multiple sclerosis, different types of cancer, and autoimmune diseases. Among their offerings are moNATor, a pioneering laboratory test designed for dose monitoring in multiple sclerosis for both medical professionals and patients, and Viraspec, a saliva-based test kit for COVID-19 detection.
Precio por acción
$0.04057595
Última sincronización: 2024-08-05
Capitalización bursátil
$863.62K
Cambio (1 día)
0.31%
Cambio (1 año)
0.00%
País
SE
Comercio AegirBio AB (publ) (AEGIR)

Categoría

Ganancias de AegirBio AB (publ) (AEGIR)
Ganancias en Sep 2024 TTM: $-3.81M
Secondo gli ultimi rapporti finanziari di AegirBio AB (publ), gli utili attuali della società sono $-3.81M. Nel 2022, la società ha registrato un utile di $-34.94M, una disminución en comparación con agli utili del 2021, che erano di $-10.24M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de AegirBio AB (publ) desde 2019 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $-3.81M -37.26%
2023 $-6.07M -82.64%
2022 $-34.94M 241.24%
2021 $-10.24M 36.29%
2020 $-7.51M 28,276,939.29%
2019 $-26.57 0.00%
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$3.81B -100,104.94%
US
$4.11B -108,067.95%
FR
- -
JP
$1.59B -41,880.40%
US
- -
CH